These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29018348)

  • 1. Target Identification of
    Mugumbate G; Mendes V; Blaszczyk M; Sabbah M; Papadatos G; Lelievre J; Ballell L; Barros D; Abell C; Blundell TL; Overington JP
    Front Pharmacol; 2017; 8():681. PubMed ID: 29018348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa.
    Malinga L; Brand J; Jansen van Rensburg C; Cassell G; van der Walt M
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S36-S37. PubMed ID: 28043598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive analysis of the protein-ligand interactions in crystal structures of Mycobacterium tuberculosis EthR.
    Tanina A; Wohlkönig A; Soror SH; Flipo M; Villemagne B; Prevet H; Déprez B; Moune M; Perée H; Meyer F; Baulard AR; Willand N; Wintjens R
    Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):248-258. PubMed ID: 30553830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New active leads for tuberculosis booster drugs by structure-based drug discovery.
    Tatum NJ; Liebeschuetz JW; Cole JC; Frita R; Herledan A; Baulard AR; Willand N; Pohl E
    Org Biomol Chem; 2017 Dec; 15(48):10245-10255. PubMed ID: 29182187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator.
    Engohang-Ndong J; Baillat D; Aumercier M; Bellefontaine F; Besra GS; Locht C; Baulard AR
    Mol Microbiol; 2004 Jan; 51(1):175-88. PubMed ID: 14651620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
    Brossier F; Veziris N; Truffot-Pernot C; Jarlier V; Sougakoff W
    Antimicrob Agents Chemother; 2011 Jan; 55(1):355-60. PubMed ID: 20974869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of EthR in a ligand bound conformation reveals therapeutic perspectives against tuberculosis.
    Frénois F; Engohang-Ndong J; Locht C; Baulard AR; Villeret V
    Mol Cell; 2004 Oct; 16(2):301-7. PubMed ID: 15494316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the TetR/CamR family repressor Mycobacterium tuberculosis EthR implicated in ethionamide resistance.
    Dover LG; Corsino PE; Daniels IR; Cocklin SL; Tatituri V; Besra GS; Fütterer K
    J Mol Biol; 2004 Jul; 340(5):1095-105. PubMed ID: 15236969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters.
    Nikiforov PO; Surade S; Blaszczyk M; Delorme V; Brodin P; Baulard AR; Blundell TL; Abell C
    Org Biomol Chem; 2016 Feb; 14(7):2318-26. PubMed ID: 26806381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide.
    Zhang HN; Xu ZW; Jiang HW; Wu FL; He X; Liu Y; Guo SJ; Li Y; Bi LJ; Deng JY; Zhang XE; Tao SC
    Sci Rep; 2017 Jul; 7(1):5860. PubMed ID: 28725053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Mycobacterium tuberculosis transcriptional repressor EthR inhibitors: Shape-based search and machine learning studies.
    Chikhale RV; Eldesoky GE; Kolpe MS; Suryawanshi VS; Patil PC; Bhowmick S
    Heliyon; 2024 Mar; 10(5):e26802. PubMed ID: 38434349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment Screening against the EthR-DNA Interaction by Native Mass Spectrometry.
    Chan DS; Mendes V; Thomas SE; McConnell BN; Matak-Vinković D; Coyne AG; Blundell TL; Abell C
    Angew Chem Int Ed Engl; 2017 Jun; 56(26):7488-7491. PubMed ID: 28513917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural activation of the transcriptional repressor EthR from Mycobacterium tuberculosis by single amino acid change mimicking natural and synthetic ligands.
    Carette X; Blondiaux N; Willery E; Hoos S; Lecat-Guillet N; Lens Z; Wohlkönig A; Wintjens R; Soror SH; Frénois F; Dirié B; Villeret V; England P; Lippens G; Deprez B; Locht C; Willand N; Baulard AR
    Nucleic Acids Res; 2012 Apr; 40(7):3018-30. PubMed ID: 22156370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mycobacterium tuberculosis transcriptional repressor EthR is negatively regulated by Serine/Threonine phosphorylation.
    Leiba J; Carrère-Kremer S; Blondiaux N; Dimala MM; Wohlkönig A; Baulard A; Kremer L; Molle V
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1132-8. PubMed ID: 24667600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic EthR inhibitors boost antituberculous activity of ethionamide.
    Willand N; Dirié B; Carette X; Bifani P; Singhal A; Desroses M; Leroux F; Willery E; Mathys V; Déprez-Poulain R; Delcroix G; Frénois F; Aumercier M; Locht C; Villeret V; Déprez B; Baulard AR
    Nat Med; 2009 May; 15(5):537-44. PubMed ID: 19412174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition.
    Ang ML; Zainul Rahim SZ; Shui G; Dianiškova P; Madacki J; Lin W; Koh VH; Martinez Gomez JM; Sudarkodi S; Bendt A; Wenk M; Mikušová K; Korduláková J; Pethe K; Alonso S
    Infect Immun; 2014 May; 82(5):1850-9. PubMed ID: 24566628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors.
    Flipo M; Desroses M; Lecat-Guillet N; Dirié B; Carette X; Leroux F; Piveteau C; Demirkaya F; Lens Z; Rucktooa P; Villeret V; Christophe T; Jeon HK; Locht C; Brodin P; Déprez B; Baulard AR; Willand N
    J Med Chem; 2011 Apr; 54(8):2994-3010. PubMed ID: 21417236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative Binding Energies Predict Crystallographic Binding Modes of Ethionamide Booster Lead Compounds.
    Tatum NJ; Duarte F; Kamerlin SCL; Pohl E
    J Phys Chem Lett; 2019 May; 10(9):2244-2249. PubMed ID: 30965004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis.
    Flipo M; Willand N; Lecat-Guillet N; Hounsou C; Desroses M; Leroux F; Lens Z; Villeret V; Wohlkönig A; Wintjens R; Christophe T; Kyoung Jeon H; Locht C; Brodin P; Baulard AR; Déprez B
    J Med Chem; 2012 Jul; 55(14):6391-402. PubMed ID: 22738293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EthA/R-Independent Killing of
    Ang MLT; Zainul Rahim SZ; de Sessions PF; Lin W; Koh V; Pethe K; Hibberd ML; Alonso S
    Front Microbiol; 2017; 8():710. PubMed ID: 28487681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.